Literature DB >> 7077091

Estimating the effects of nosocomial infections on the length of hospitalization.

M S Green, E Rubinstein, P Amit.   

Abstract

Increased length of hospitalization due to nosocomial infections has generally been calculated from the arithmetic mean of the differences in hospital stay of persons with nosocomial infections and their matched control patients. This method may yield estimates inflated by a few extreme values. Data from a prospective study of nosocomial infections in patients hospitalized in surgical and orthopedic services in a large hospital in Israel are used to illustrate a modified statistical approach to this problem. The geometric mean of the ratio of length of hospitalization of 57 patients with nosocomial infections to matched control patients was determined. The increased mean hospital stay was estimated at 4.5 days for urinary tract infection, 11.9 days for surgical wound infection, and 25 days for "double infection." These figures were lower than those derived from calculation of the arithmetic mean of excess hospital stay and suggest that this modification should be incorporated in future studies of this nature.

Entities:  

Mesh:

Year:  1982        PMID: 7077091     DOI: 10.1093/infdis/145.2.667

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Reduction in surgical wound infection rates associated with reporting data to surgeons.

Authors:  G Taylor; M Buchanan-Chell; T Kirkland; M McKenzie; B Sutherland; R Wiens
Journal:  Can J Infect Dis       Date:  1994-11

2.  Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.

Authors:  J R Johnson; P Delavari; M Azar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

3.  Estimation of prolongation of hospital stay attributable to nosocomial infections: new approaches based on multistate models.

Authors:  G Schulgen; M Schumacher
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization.

Authors:  A A Vegas; V M Jodra; M L García
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

5.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit.

Authors:  I Kappstein; G Schulgen; U Beyer; K Geiger; M Schumacher; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

6.  Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens.

Authors:  J R Johnson; T Berggren; A J Conway
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.

Authors:  Euan Burton; Purushottam V Gawande; Nandadeva Yakandawala; Karen LoVetri; George G Zhanel; Tony Romeo; Albert D Friesen; Srinivasa Madhyastha
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

8.  Preparation and in-vitro Antibacterial Evaluation of Electroless Silver Coated Polymers.

Authors:  Mohammad Reza Fazeli; Vahid Hosseini; Fazel Shamsa; Hossein Jamalifar
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

9.  Accuracy of urine flow cytometry and urine test strip in predicting relevant bacteriuria in different patient populations.

Authors:  Stefano Bassetti; Adrian Egli; Christian Gehringer; Axel Regeniter; Katharina Rentsch; Sarah Tschudin-Sutter
Journal:  BMC Infect Dis       Date:  2021-02-25       Impact factor: 3.090

10.  Appropriate use of indwelling urethra catheters in hospitalized patients: results of a multicentre prevalence study.

Authors:  Irálice A V Jansen; Titia E M Hopmans; Jan C Wille; Peterhans J van den Broek; Tjallie I I van der Kooi; Birgit H B van Benthem
Journal:  BMC Urol       Date:  2012-09-06       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.